Immune and inflammatory responses to DNA damage in cancer and aging

Mechanisms of Ageing and Development

Volumn 165, Issue , 2017, Pages 10-16

  Soria Valles, Clara ^a   López Soto, Alejandro ^b   Osorio, Fernando G ^a   López Otín, Carlos ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Aging; Cancer; DNA damage response; Immunity; Inflammation

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR PROTEIN;

AGING; ARTICLE; CARCINOGENESIS; CELL DAMAGE; CELL SURVIVAL; DNA DAMAGE; GENOMIC INSTABILITY; HOMEOSTASIS; HUMAN; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATION; MALIGNANT NEOPLASM; NONHUMAN; PRIORITY JOURNAL; ANIMAL; GENETICS; IMMUNOLOGY; NEOPLASM; PATHOLOGY;

AGING; ANIMALS; DNA DAMAGE; GENOMIC INSTABILITY; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; NF-KAPPA B;

EID: 84992051167     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2016.10.004     Document Type: Article

References (81)

1. Alt, F.W., Zhang, Y., Meng, F.L., Guo, C., Schwer, B., Mechanisms of programmed DNA lesions and genomic instability in the immune system. Cell 152 (2013), 417–429.
2. Baker, D.J., Wijshake, T., Tchkonia, T., LeBrasseur, N.K., Childs, B.G., van de Sluis, B., Kirkland, J.L., van Deursen, J.M., Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479 (2011), 232–236.
3. Baker, D.J., Childs, B.G., Durik, M., Wijers, M.E., Sieben, C.J., Zhong, J., Saltness, R.A., Jeganathan, K.B., Verzosa, G.C., Pezeshki, A., Khazaie, K., Miller, J.D., van Deursen, J.M., Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530 (2016), 184–189.
4. Bartkova, J., Horejsi, Z., Koed, K., Kramer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J.M., Lukas, C., Orntoft, T., Lukas, J., Bartek, J., DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434 (2005), 864–870.
5. Campoli, M., Ferrone, S., HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance. Oncogene 27 (2008), 5869–5885.
6. Candeias, S.M., Testard, I., The many interactions between the innate immune system and the response to radiation. Cancer Lett. 368 (2015), 173–178.
7. Carrero, D., Soria-Valles, C., Lopez-Otin, C., Hallmarks of progeroid syndromes: lessons from mice and reprogrammed cells. Dis. Model Mech. 9 (2016), 719–735.
8. Casey, S.C., Tong, L., Li, Y., Do, R., Walz, S., Fitzgerald, K.N., Gouw, A.M., Baylot, V., Gutgemann, I., Eilers, M., Felsher, D.W., MYC regulates the antitumor immune response through CD47 and PD-L1. Science 352 (2016), 227–231.
9. Chatzinikolaou, G., Karakasilioti, I., Garinis, G.A., DNA damage and innate immunity: links and trade-offs. Trends Immunol. 35 (2014), 429–435.
10. Chiappinelli, K.B., Strissel, P.L., Desrichard, A., Li, H., Henke, C., Akman, B., Hein, A., Rote, N.S., Cope, L.M., Snyder, A., Makarov, V., Budhu, S., Slamon, D.J., Wolchok, J.D., Pardoll, D.M., Beckmann, M.W., Zahnow, C.A., Merghoub, T., Chan, T.A., Baylin, S.B., Strick, R., Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses. Cell 162 (2015), 974–986.
11. Chitadze, G., Lettau, M., Bhat, J., Wesch, D., Steinle, A., Furst, D., Mytilineos, J., Kalthoff, H., Janssen, O., Oberg, H.H., Kabelitz, D., Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the a disintegrin and metalloproteases 10 and 17. Int. J. Cancer 133 (2013), 1557–1566.
12. Chiu, Y.H., Macmillan, J.B., Chen, Z.J., RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138 (2009), 576–591.
13. Duxin, J.P., Walter, J.C., What is the DNA repair defect underlying Fanconi anemia?. Curr. Opin. Cell Biol. 37 (2015), 49–60.
14. Ermolaeva, M., Schumacher, B., The innate immune system as mediator of systemic DNA damage responses. Commun. Integr. Biol., 6, 2013, e26926.
15. Ermolaeva, M.A., Schumacher, B., Systemic DNA damage responses: organismal adaptations to genome instability. Trends Genet. 30 (2014), 95–102.
16. Ferguson, B.J., Mansur, D.S., Peters, N.E., Ren, H., Smith, G.L., DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife, 1, 2012, e00047.
17. Gaillard, H., Garcia-Muse, T., Aguilera, A., Replication stress and cancer. Nat. Rev. Cancer 15 (2015), 276–289.
18. Gasser, S., Orsulic, S., Brown, E.J., Raulet, D.H., The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436 (2005), 1186–1190.
19. Gazouli, M., Kokotas, S., Zoumpourlis, V., Zacharatos, P., Mariatos, G., Kletsas, D., Perunovic, B., Athanasiou, A., Kittas, C., Gorgoulis, V., The complement inhibitor CD59 and the lymphocyte function-associated antigen-3 (LFA-3, CD58) genes possess functional binding sites for the p53 tumor suppressor protein. Anticancer Res. 22 (2002), 4237–4241.
20. Gorgoulis, V.G., Zacharatos, P., Kotsinas, A., Kletsas, D., Mariatos, G., Zoumpourlis, V., Ryan, K.M., Kittas, C., Papavassiliou, A.G., p53 activates ICAM-1 (CD54) expression in an NF-kappaB-independent manner. EMBO J. 22 (2003), 1567–1578.
21. Gorgoulis, V.G., Vassiliou, L.V., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., Ditullio, R.A. Jr., Kastrinakis, N.G., Levy, B., Kletsas, D., Yoneta, A., Herlyn, M., Kittas, C., Halazonetis, T.D., Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434 (2005), 907–913.
22. Groh, V., Wu, J., Yee, C., Spies, T., Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419 (2002), 734–738.
23. Guleria, A., Chandna, S., ATM kinase: much more than a DNA damage responsive protein. DNA Repair (Amst.), 2015.
24. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144 (2011), 646–674.
25. Harberts, E., Gaspari, A.A., TLR signaling and DNA repair: are they associated?. J. Invest. Dermatol. 133 (2013), 296–302.
26. Helleday, T., Eshtad, S., Nik-Zainal, S., Mechanisms underlying mutational signatures in human cancers. Nat. Rev. Genet. 15 (2014), 585–598.
27. Ho, S.S., Zhang, W.Y., Tan, N.Y., Khatoo, M., Suter, M.A., Tripathi, S., Cheung, F.S., Lim, W.K., Tan, P.H., Ngeow, J., Gasser, S., The DNA structure-specific endonuclease MUS81 mediates DNA sensor STING-dependent host rejection of prostate cancer cells. Immunity 44 (2016), 1177–1189.
28. Iannello, A., Thompson, T.W., Ardolino, M., Lowe, S.W., Raulet, D.H., p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. J. Exp. Med. 210 (2013), 2057–2069.
29. Ishikawa, H., Barber, G.N., STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455 (2008), 674–678.
30. Jurk, D., Wilson, C., Passos, J.F., Oakley, F., Correia-Melo, C., Greaves, L., Saretzki, G., Fox, C., Lawless, C., Anderson, R., Hewitt, G., Pender, S.L., Fullard, N., Nelson, G., Mann, J., van de Sluis, B., Mann, D.A., von Zglinicki, T., Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat. Commun., 2, 2014, 4172.
31. Kang, C., Xu, Q., Martin, T.D., Li, M.Z., Demaria, M., Aron, L., Lu, T., Yankner, B.A., Campisi, J., Elledge, S.J., The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science, 349, 2015, aaa5612.
32. Kastan, M.B., Lim, D.S., Kim, S.T., Yang, D., ATM—a key determinant of multiple cellular responses to irradiation. Acta Oncol. 40 (2001), 686–688.
33. Kidane, D., Chae, W.J., Czochor, J., Eckert, K.A., Glazer, P.M., Bothwell, A.L., Sweasy, J.B., Interplay between DNA repair and inflammation, and the link to cancer. Crit. Rev. Biochem. Mol. Biol. 49 (2014), 116–139.
34. Kraemer, K.H., Patronas, N.J., Schiffmann, R., Brooks, B.P., Tamura, D., DiGiovanna, J.J., Xeroderma pigmentosum, trichothiodystrophy and cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience 145 (2007), 1388–1396.
35. Kroemer, G., Galluzzi, L., Kepp, O., Zitvogel, L., Immunogenic cell death in cancer therapy. Annu. Rev. Immunol. 31 (2013), 51–72.
36. Krokan, H.E., Bjoras, M., Base excision repair. Cold Spring Harb. Perspect. Biol., 5, 2013, a012583.
37. Lopez-Otin, C., Blasco, M.A., Partridge, L., Serrano, M., Kroemer, G., The hallmarks of aging. Cell 153 (2013), 1194–1217.
38. Lopez-Otin, C., Galluzzi, L., Freije, J.M., Madeo, F., Kroemer, G., Metabolic control of longevity. Cell 166 (2016), 802–821.
39. Lopez-Soto, A., Folgueras, A.R., Seto, E., Gonzalez, S., HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer. Oncogene 28 (2009), 2370–2382.
40. Lopez-Soto, A., Huergo-Zapico, L., Acebes-Huerta, A., Villa-Alvarez, M., Gonzalez, S., NKG2D signaling in cancer immunosurveillance. Int. J. Cancer 136 (2015), 1741–1750.
41. Marino, G., Ugalde, A.P., Fernandez, A.F., Osorio, F.G., Fueyo, A., Freije, J.M., Lopez-Otin, C., Insulin-like growth factor 1 treatment extends longevity in a mouse model of human premature aging by restoring somatotroph axis function. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 16268–16273.
42. Masutani, C., Sugasawa, K., Yanagisawa, J., Sonoyama, T., Ui, M., Enomoto, T., Takio, K., Tanaka, K., van der Spek, P.J., Bootsma, D., et al. Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23. EMBO J. 13 (1994), 1831–1843.
43. Maude, S.L., Frey, N., Shaw, P.A., Aplenc, R., Barrett, D.M., Bunin, N.J., Chew, A., Gonzalez, V.E., Zheng, Z., Lacey, S.F., Mahnke, Y.D., Melenhorst, J.J., Rheingold, S.R., Shen, A., Teachey, D.T., Levine, B.L., June, C.H., Porter, D.L., Grupp, S.A., Chimeric antigen receptor T cells for sustained remissions in leukemia. N. Engl. J. Med. 371 (2014), 1507–1517.
44. Miyamoto, S., Nuclear initiated NF-kappaB signaling: NEMO and ATM take center stage. Cell Res. 21 (2011), 116–130.
45. Morvan, M.G., Lanier, L.L., NK cells and cancer: you can teach innate cells new tricks. Nat. Rev. Cancer 16 (2016), 7–19.
46. Muenst, S., Laubli, H., Soysal, S.D., Zippelius, A., Tzankov, A., Hoeller, S., The immune system and cancer evasion strategies: therapeutic concepts. J. Intern. Med., 2016.
47. Murga, M., Campaner, S., Lopez-Contreras, A.J., Toledo, L.I., Soria, R., Montana, M.F., D'Artista, L., Schleker, T., Guerra, C., Garcia, E., Barbacid, M., Hidalgo, M., Amati, B., Fernandez-Capetillo, O., Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors. Nat. Struct. Mol. Biol. 18 (2011), 1331–1335.
48. Niedernhofer, L.J., Garinis, G.A., Raams, A., Lalai, A.S., Robinson, A.R., Appeldoorn, E., Odijk, H., Oostendorp, R., Ahmad, A., van Leeuwen, W., Theil, A.F., Vermeulen, W., van der Horst, G.T., Meinecke, P., Kleijer, W.J., Vijg, J., Jaspers, N.G., Hoeijmakers, J.H., A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 444 (2006), 1038–1043.
49. Nishi, R., Okuda, Y., Watanabe, E., Mori, T., Iwai, S., Masutani, C., Sugasawa, K., Hanaoka, F., Centrin 2 stimulates nucleotide excision repair by interacting with xeroderma pigmentosum group C protein. Mol. Cell Biol. 25 (2005), 5664–5674.
50. O'Connor, M.J., Targeting the DNA damage response in cancer. Mol. Cell 60 (2015), 547–560.
51. Osorio, F.G., Barcena, C., Soria-Valles, C., Ramsay, A.J., de Carlos, F., Cobo, J., Fueyo, A., Freije, J.M., Lopez-Otin, C., Nuclear lamina defects cause ATM-dependent NF-kappaB activation and link accelerated aging to a systemic inflammatory response. Genes Dev. 26 (2012), 2311–2324.
52. Osorio, F.G., Soria-Valles, C., Santiago-Fernandez, O., Freije, J.M., Lopez-Otin, C., NF-kappaB signaling as a driver of ageing. Int. Rev. Cell Mol. Biol. 326 (2016), 133–174.
53. Palmai-Pallag, T., Bachrati, C.Z., Inflammation-induced DNA damage and damage-induced inflammation: a vicious cycle. Microbes Infect. 16 (2014), 822–832.
54. Pateras, I.S., Havaki, S., Nikitopoulou, X., Vougas, K., Townsend, P.A., Panayiotidis, M.I., Georgakilas, A.G., Gorgoulis, V.G., The DNA damage response and immune signaling alliance: is it good or bad? Nature decides when and where. Pharmacol. Ther. 154 (2015), 36–56.
55. Pena-Diaz, J., Jiricny, J., Mammalian mismatch repair: error-free or error-prone?. Trends Biochem. Sci. 37 (2012), 206–214.
56. Pol, J., Vacchelli, E., Aranda, F., Castoldi, F., Eggermont, A., Cremer, I., Sautes-Fridman, C., Fucikova, J., Galon, J., Spisek, R., Tartour, E., Zitvogel, L., Kroemer, G., Galluzzi, L., Trial watch: immunogenic cell death inducers for anticancer chemotherapy. Oncoimmunology, 4, 2015, e1008866.
57. Rakhra, K., Bachireddy, P., Zabuawala, T., Zeiser, R., Xu, L., Kopelman, A., Fan, A.C., Yang, Q., Braunstein, L., Crosby, E., Ryeom, S., Felsher, D.W., CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation. Cancer Cell 18 (2010), 485–498.
58. Ribezzo, F., Shiloh, Y., Schumacher, B., Systemic DNA damage responses in aging and diseases. Semin. Cancer Biol., 2016.
59. Rodier, F., Coppe, J.P., Patil, C.K., Hoeijmakers, W.A., Munoz, D.P., Raza, S.R., Freund, A., Campeau, E., Davalos, A.R., Campisi, J., Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 11 (2009), 973–979.
60. Roth, S., Rottach, A., Lotz-Havla, A.S., Laux, V., Muschaweckh, A., Gersting, S.W., Muntau, A.C., Hopfner, K.P., Jin, L., Vanness, K., Petrini, J.H., Drexler, I., Leonhardt, H., Ruland, J., Rad50-CARD9 interactions link cytosolic DNA sensing to IL-1beta production. Nat. Immunol. 15 (2014), 538–545.
61. Ryan, B.M., Pine, S.R., Chaturvedi, A.K., Caporaso, N., Harris, C.C., A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. J. Thorac. Oncol. 9 (2014), 1494–1503.
62. Schreiber, R.D., Old, L.J., Smyth, M.J., Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331 (2011), 1565–1570.
63. Senovilla, L., Galluzzi, L., Zitvogel, L., Kroemer, G., Immunosurveillance as a regulator of tissue homeostasis. Trends Immunol. 34 (2013), 471–481.
64. Shapiro, R.S., Malignancies in the setting of primary immunodeficiency: implications for hematologists/oncologists. Am. J. Hematol. 86 (2011), 48–55.
65. Sharma, P., Allison, J.P., Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell 161 (2015), 205–214.
66. Shaw, A.C., Goldstein, D.R., Montgomery, R.R., Age-dependent dysregulation of innate immunity. Nat. Rev. Immunol. 13 (2013), 875–887.
67. Shiloh, Y., Ziv, Y., The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat. Rev. Mol. Cell Biol. 14 (2013), 197–210.
68. Siddiqui, M.S., Francois, M., Fenech, M.F., Leifert, W.R., Persistent gammaH2AX: a promising molecular marker of DNA damage and aging. Mutat. Res. Rev. Mutat. Res. 766 (2015), 1–19.
69. Smith, L.K., He, Y., Park, J.S., Bieri, G., Snethlage, C.E., Lin, K., Gontier, G., Wabl, R., Plambeck, K.E., Udeochu, J., Wheatley, E.G., Bouchard, J., Eggel, A., Narasimha, R., Grant, J.L., Luo, J., Wyss-Coray, T., Villeda, S.A., Beta2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis. Nat. Med. 21 (2015), 932–937.
70. Soria-Valles, C., Lopez-Otin, C., iPSCs: on the road to reprogramming aging. Trends Mol. Med. 22 (2016), 713–724.
71. Soria-Valles, C., Osorio, F.G., Gutierrez-Fernandez, A., De Los Angeles, A., Bueno, C., Menendez, P., Martin-Subero, J.I., Daley, G.Q., Freije, J.M., Lopez-Otin, C., NF-kappaB activation impairs somatic cell reprogramming in ageing. Nat. Cell Biol. 17 (2015), 1004–1013.
72. Soria-Valles, C., Gutierrez-Fernandez, A., Osorio, F.G., Carrero, D., Ferrando, A.A., Colado, E., Fernandez-Garcia, M.S., Bonzon-Kulichenko, E., Vazquez, J., Fueyo, A., Lopez-Otin, C., MMP-25 metalloprotease regulates innate immune response through NF-kappaB signaling. J. Immunol. 197 (2016), 296–302.
73. Soriani, A., Zingoni, A., Cerboni, C., Iannitto, M.L., Ricciardi, M.R., Di Gialleonardo, V., Cippitelli, M., Fionda, C., Petrucci, M.T., Guarini, A., Foa, R., Santoni, A., ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 113 (2009), 3503–3511.
74. Swann, J.B., Smyth, M.J., Immune surveillance of tumors. J. Clin. Invest. 117 (2007), 1137–1146.
75. Tang, M.L., Khan, M.K., Croxford, J.L., Tan, K.W., Angeli, V., Gasser, S., The DNA damage response induces antigen presenting cell-like functions in fibroblasts. Eur. J. Immunol. 44 (2014), 1108–1118.
76. Textor, S., Fiegler, N., Arnold, A., Porgador, A., Hofmann, T.G., Cerwenka, A., Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2. Cancer Res. 71 (2011), 5998–6009.
77. Tilstra, J.S., Robinson, A.R., Wang, J., Gregg, S.Q., Clauson, C.L., Reay, D.P., Nasto, L.A., St Croix, C.M., Usas, A., Vo, N., Huard, J., Clemens, P.R., Stolz, D.B., Guttridge, D.C., Watkins, S.C., Garinis, G.A., Wang, Y., Niedernhofer, L.J., Robbins, P.D., NF-kappaB inhibition delays DNA damage-induced senescence and aging in mice. J. Clin. Invest. 122 (2012), 2601–2612.
78. Vajdic, C.M., Mao, L., van Leeuwen, M.T., Kirkpatrick, P., Grulich, A.E., Riminton, S., Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency?. Blood 116 (2010), 1228–1234.
79. Wang, J., Geiger, H., Rudolph, K.L., Immunoaging induced by hematopoietic stem cell aging. Curr. Opin. Immunol. 23 (2011), 532–536.
80. Wang, H., Zhang, X., Teng, L., Legerski, R.J., DNA damage checkpoint recovery and cancer development. Exp. Cell Res. 334 (2015), 350–358.
81. Zhang, X., Brann, T.W., Zhou, M., Yang, J., Oguariri, R.M., Lidie, K.B., Imamichi, H., Huang, D.W., Lempicki, R.A., Baseler, M.W., Veenstra, T.D., Young, H.A., Lane, H.C., Imamichi, T., Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN. J. Immunol. 186 (2011), 4541–4545.